Company intelligence
Stealth Biotech
Coming soon
Biotechnology Research
156 employees
Founded 2023
6 public signals
About Stealth Biotech
A stealth mode biotech startup located in San Mateo county, CA.
Verified activity
Signals from Stealth Biotech
6 published signals
Research & Knowledge
Stealth Biotech published recent clinical findings showing that some individuals diagnosed with relapsing-remitting multiple sclerosis (MS) can benefit from anti-CD20 B cell therapies, indicating a potentially pathogenic role for autoreactive B cells.
Reported by Dr. Andreas Herrmann, PhD
Research & Knowledge
Stealth Biotech profiled 4,336 plasma samples from 1,714 patients across five tumor types and 16 cohorts spanning Europe and North America, longitudinally sampled during five immune-checkpoint inhibitor-based treatment modalities, including fecal microbiota transplantation.
Reported by Dr. Andreas Herrmann, PhD
Research & Knowledge
Stealth Biotech identified five metabolites, age, body mass index, and renal function as predictors of 12-month progression-free survival using a multimodal machine-learning framework integrating 154 metabolites with clinical variables.
Reported by Dr. Andreas Herrmann, PhD
Research & Knowledge
Stealth Biotech found that histidine-rich diets improved progression-free survival in patients lacking dysbiotic microbiome signatures associated with histidine catabolism.
Reported by Dr. Andreas Herrmann, PhD
Research & Knowledge
Stealth Biotech found that histidine was a favorable prognostic feature of survival, while long-chain fatty acids and succinate were negatively associated with outcome.
Reported by Dr. Andreas Herrmann, PhD
Research & Knowledge
Stealth Biotech achieved areas under the curve of 0.88 in training and 0.73 in validation cohorts of 105 and 30 patients, respectively, and generalized across seven external cohorts.
Reported by Dr. Andreas Herrmann, PhD